Orionis Biosciences Orionis Biosciences is a company that specializes in drug discovery and development with a focus on oncology and immunotherapies. | |||
Founding Date | Founding Date 2001 | Founding Date 2015 | Founding Date 1998 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Lund, SE HQ | Locations Waltham, US HQ Gent, BE | Locations Seongnam-si, KR HQ |
Employees | Employees 1555% decrease | Employees 52 | Employees 50 |
Financial | |||
Revenue (est.) | Revenue (est.) kr514k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₩99.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩438.8m (FY, 2025) |
Gross profit | Gross profit kr1.1m (FY, 2025) | Gross profit N/A | Gross profit ₩100b (FY, 2025) |
Net income | Net income (kr51.4m) (FY, 2025) | Net income N/A | Net income ₩54.4b (FY, 2025) |
Orionis Biosciences is a company that specializes in drug discovery and development with a focus on oncology and immunotherapies.
View company
Oscotec is a clinical stage drug discovery and development company.
View company